Goodwill in USD of Ernexa Therapeutics Inc. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Ernexa Therapeutics Inc. quarterly Goodwill history and change rate from Q4 2010 to Q3 2025.
  • Ernexa Therapeutics Inc. Goodwill for the quarter ending 30 Sep 2025 was $2,044,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Ernexa Therapeutics Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,044,000 $0 0% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $2,044,000 $0 0% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $2,044,000 $0 0% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $2,044,000 $0 0% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $2,044,000 $0 0% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $2,044,000 $0 0% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $2,044,000 $0 0% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $2,044,000 $0 0% 31 Dec 2023 10-K 12 Mar 2025 2024 FY
Q3 2023 $2,044,000 $0 0% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $2,044,000 $0 0% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $2,044,000 $0 0% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $2,044,000 $0 0% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $2,044,000 +$253 +0.01% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $2,044,000 +$253 +0.01% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $2,044,000 +$253 +0.01% 31 Mar 2022 10-Q 01 Jul 2022 2022 Q1
Q4 2021 $2,044,000 $0 0% 31 Dec 2021 10-K 20 Mar 2023 2022 FY
Q3 2021 $2,043,747 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $2,043,747 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 $2,043,747 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $2,044,000 +$1,348,000 +194% 31 Dec 2020 10-K/A 01 Jul 2022 2021 FY
Q4 2019 $696,000 +$29,000 +4.3% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $687,000 -$289,000 -30% 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $695,000 -$260,000 -27% 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $681,000 -$297,000 -30% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 $667,000 -$337,000 -34% 31 Dec 2018 10-K 19 Mar 2020 2019 FY
Q3 2018 $976,000 -$36,000 -3.6% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $955,000 -$13,000 -1.3% 30 Jun 2018 10-Q 06 Aug 2018 2018 Q2
Q1 2018 $978,000 +$32,000 +3.4% 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 $1,004,000 +$67,000 +7.2% 31 Dec 2017 10-K 22 Mar 2019 2018 FY
Q3 2017 $1,012,000 +$53,000 +5.5% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 $968,000 -$5,000 -0.51% 30 Jun 2017 10-Q 04 Aug 2017 2017 Q2
Q1 2017 $946,000 -$26,000 -2.7% 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 $937,000 +$28,000 +3.1% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q3 2016 $959,000 +$19,000 +2% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $973,000 -$47,000 -4.6% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 $972,000 -$25,000 -2.5% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 $909,000 -$175,000 -16% 31 Dec 2015 10-K 09 Mar 2017 2016 FY
Q3 2015 $940,000 -$190,000 -17% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 $1,020,000 -$161,000 -14% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 $997,000 -$142,000 -12% 31 Mar 2015 10-Q 08 May 2015 2015 Q1
Q4 2014 $1,084,000 -$95,000 -8.1% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 $1,130,000 -$92,000 -7.5% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 $1,181,000 -$16,000 -1.3% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 $1,139,000 -$99,000 -8% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 $1,179,000 -$86,000 -6.8% 31 Dec 2013 10-K 27 Mar 2015 2014 FY
Q3 2013 $1,222,000 -$59,000 -4.6% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 $1,197,000 -$33,000 -2.7% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 $1,238,000 -$26,000 -2.1% 31 Mar 2013 10-Q 13 May 2013 2013 Q1
Q4 2012 $1,265,000 +$29,000 +2.3% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 $1,281,000 +$60,000 +4.9% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 $1,230,000 -$61,000 -4.7% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 $1,264,000 31 Mar 2012 10-Q 11 May 2012 2012 Q1
Q4 2011 $1,236,000 -$25,000 -2% 31 Dec 2011 10-K 29 Mar 2013 2012 FY
Q3 2011 $1,221,000 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 $1,291,000 30 Jun 2011 10-Q 12 Aug 2011 2011 Q2
Q4 2010 $1,261,000 31 Dec 2010 10-K 30 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.